Interleukin Genetics
This article was originally published in The Tan Sheet
Executive Summary
Waltham, Mass.-based biotech company has signed letter of intent with "undisclosed major consumer products company" to market genomics-based nutritional and skin-care products, firm announces Sept. 3. Interleukin "uses functional genomics to develop diagnostic, therapeutic and nutraceutical products based on the genetic variations in people to help prevent or treat diseases of inflammation." A partnered study with Kaiser Permanente on diabetic patients' genetic risk for heart disease will be released this fall, may lead to diagnostic products, firm adds...